The sell side suggests that the sophisticated boys have more to go:all good,just have to wait for them to finish.We should get a higher trading range then,but it's not going to really run until there are some promising sales figures presented to the market-that could be next year. I would expect the listing to be postponed:without sales,KSX would not be able to meet listing requirements.These guys just burn the cash and will need to burn more with the increasing roll-out.No doubt they will have to be generous with the sophisticated boys again-more selling.[some know that pay-day is not around the corner] The Omron deal demonstrates the real potential of this outfit:blending the products with the existing asthma infrastructure.Exciting news for long-termers. Patience is the key-as an ORD holder,I know this can reward the 'grit-your-teeth' approach.KSX is still the ugly duckling-but will explode when the right sales figures are produced.
Cheers to all holders
KSX Price at posting:
1.6¢ Sentiment: LT Buy Disclosure: Held
